Longboard Pharmaceuticals, Inc. Stock Split Ratio
Longboard Pharmaceuticals, Inc. reported Stock Split Ratio of 138.00% for the 0-month period ending 2021-03-05, per its 10-Q filed 2022-11-03.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2023-03-02
- 2021-03-05: Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month 138.00%; Stockholders' Equity Note, Stock Split, Conversion Ratio 138.00%.
- 2020-10-27: Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month 278300.00%; Stockholders' Equity Note, Stock Split, Conversion Ratio 278300.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month | Stockholders' Equity Note, Stock Split, Conversion Ratio |
|---|---|---|
| 2021-03-05 | 138.00% 10-Q · filed 2022-11-03 | 138.00% 10-K · filed 2023-03-02 |
| 2020-10-27 | 278300.00% 10-Q · filed 2022-11-03 | 278300.00% 10-K · filed 2022-03-03 |